New insights into the pathogenesis of inherited phosphate wasting disorders

Bone

Volumn 25, Issue 1, 1999, Pages 131-135

  Econs, M J ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Autosomal dominant hypophosphatemic rickets; Familial hypophosphatemia; Hypophosphatemia; Hypophosphatemic bone disease; PHEX; X linked hypophosphatemic rickets

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; PHOSPHATE; PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 12P; GENE LOCUS; GENE MUTATION; MOLECULAR CLONING; PATHOGENESIS; PHOSPHATE DEFICIENCY; PHOSPHATE METABOLISM; PHOSPHATE TRANSPORT; REVIEW; RICKETS; X CHROMOSOME LINKAGE;

EID: 0032993821     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00108-8     Document Type: Article

References (59)

1. Beck L., Soumounou Y., Martel J., et al. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest. 99:1997;1200-1209.
2. Bianchine J.W., Stambler A.A., Harrison H.E. Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects: Original Article Series. 7:1971;287-295.
3. Bradbury P.G., Brenton D.P., Stern G.M. Neurological involvement in X-linked hypophosphatemic rickets. J Neurol, Neurosurg Psychiatry. 50:1987;810-812.
4. Cai Q., Hodgson S.F., Kao P.C., et al. Brief report inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia . New Engl J Med. 330:1994;1645-1649.
5. Cartwright D.W., Masel J.P., Latham S.C. The lumbar spinal canal in hypophosphatemic vitamin D-resistant rickets. Aust NZ J Med. 11:1981;154-157.
6. Coleman E.N., Foote J.B. Craniostenosis with familial vitamin-D-resistant rickets. Br Med J. 1954;561-562.
7. Davies M., Stanbury S.W. The rheumatic manifestations of metabolic bone disease. Clin Rheumat Dis. 7:1981;595-646.
8. Dixon P.H., Christie P.T., Wooding C., et al. Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab. 83:1998;3615-3623.
9. Drezner M.K., Haussler M.R. Correspondence. N Engl J Med. 300:1979;435.
10. Du L., Desbarats M., Viel J., Glorieux F.H., Cawthorn C., Ecarot B. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics. 36:1996;22-28.
11. Ecarot B., Glorieux F.H., Desbarats M., Travers R., Labelle L. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Min Res. 10:1995;424-431.
12. Ecarot-Charrier B., Glorieux F.H., Travers R., Desbarats M., Bouchard F., Hinek A. Defective bone formation by transplanted Hyp mouse bone cells into normal mice. Endocrinology. 123:1988;768-773.
13. Econs M.J. Positional cloning of the HYP gene a review . Kid Int. 49:1996;1033-1037.
14. Econs M.J., Drezner M.K. Bone disease resulting from inherited disorders of renal tubule transport and vitamin D metabolism. Favus M.J., Coe F.L. Disorders of Bone and Mineral Metabolism. 1992;935-950 Raven, New York.
15. Econs M.J., Drezner M.K. Tumor-induced osteomalacia-unveiling a new hormone. N Engl J Med. 330:1994;1679-1681.
16. Econs M.J., Francis F. Positional cloning of the PEX gene new insights into the pathophysiology of X-linked hypophosphatemic rickets . Am J Physiol. 273:1997;F489-F498.
17. Econs M.J., Friedman N.E., Rowe P.S.N., et al. A PEX gene mutation is responsible for adult onset vitamin D resistant hypophosphatemic osteomalacia evidence that the disorder is not a distinct entity from X-linked hypophosphatmic rickets (HYP) . J Endocrinol Metab. 83:1998;3459-3462.
18. Econs M.J., McEnery P.T. Autosomal dominant hypophosphatemic rickets/osteomalacia clinical characterization of a novel renal phosphate wasting disorder . J Clin Endocrinol Metab. 82:1997;674-681.
19. Econs M.J., McEnery P.T., Lennon F., Speer M.C. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest. 100:1997;2653-2657.
20. Econs M.J., Rowe P.S., Francis F., et al. Fine structure mapping of the human X-linked hypophosphatemic rickets gene locus. J Clin Endocrinol Metab. 79:1994;1351-1354.
21. Econs M.J., Samsa G.P., Monger M., Drezner M.K., Feussner J.R. X-linked hypophosphatemic rickets a disease often unknown to affected patients . J Bone Min Res. 24:1994;17-24.
22. Francis F., Strom T.M., Hennig S., et al. Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Gen Res. 7:1997;573-585.
23. Harrison, H. E., Harrison, H. C. Rickets and osteomalacia. In: Disorders of Calcium and Phosphate Metabolism in Childhood and Adolescence. Philadelphia: W. B. Saunders; 1979; 230-249.
24. Holm I.A., Huang X., Kunkel L.M. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet. 60:1997;790-797.
25. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genetics. 11:1995;130-136.
26. Kos C.H., Tihy F., Econs M.J., Murer H., Lemieux N., Tenenhouse H.S. Localization of a renal sodium-phosphate cotransporter gene to human chromosome 5q35. Genomics. 19:1994;176-177.
27. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger rnas. Nucleic Acids Res. 15:1987;8125-8148.
28. Kozak M. An analysis of vertebrate m RNA sequences intimations of translational control . J Cell Biol. 115:1991;887-903.
29. Lajeunesse, D. and Delalandre, A. Evidence that the putative phophaturic product present in Hyp mouse may be modified, not produced, by osteoblasts and bone marrow stromal cells. Bone 23(Suppl. 5)546(Abstr.); 1998.
30. Lajeunesse D., Meyer R.A. Jr, Hamel L. Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse. Kid Int. 50:1996;1531-1538.
31. Lipman M.L., Panda D., Bennett H.P., et al. Cloning of human PEX cDNA expression, subcellular localization, and endopeptidase activity . J Biol Chem. 273:1998;13729-13737.
32. Lobaugh B., Drezner M.K. Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse. J Clin Invest. 71:1983;400-403.
33. Lorenz B., Francis F., Gempel K., et al. Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene. Hum Mol Genet. 7:1998;541-547.
34. Lyles K.W., Clark A.G., Drezner M.K. Serum 1,25-dihyroxyvitamin D levels in subjects with X-linked hypophophatemic rickets and osteomalacia. Calcif Tissue Int. 34:1982;125-130.
35. Machler M., Frey D., Gal A., et al. X-linked dominant hypophosphatemia is closely linked to DNA markers DXS41 and DXS43 at Xp22. Hum Genet. 73:1986;271-275.
36. Meyer R.A. Jr, Henley C.M., Meyer M.H., et al. Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, gyro (Gy) mouse. Genomics. 48:1998;289-295.
37. Meyer R.A. Jr, Meyer M.H., Gray R.W. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Min Res. 4:1989;493-500.
38. Miyauchi A., Fukase M., Tsutsumi M., Fujita T. Hemangiopericytoma-induced osteomalacia tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity . J Clin Endocrinol Metab. 67:1988;46-53.
39. Morgan J.M., Hawley W.L., Chenoweth A.I., Retan W.J., Diethelm A.G. Renal transplantation in hypophosphatemia with vitamin D-resistant rickets. Arch Int Med. 134:1974;549-552.
40. Nelson A.E., Namkung H.J., Patava J., et al. Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol Cell Endocrinol. 124:1996;17-23.
41. Nesbitt T., Coffman T.M., Griffiths R., Drezner M.K. Crosstransplantation of kidneys in normal and Hyp mice evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect . J Clin Invest. 89:1992;1453-1459.
42. Rowe P.S., Goulding J.N., Francis F., et al. The gene for X-linked hypophosphataemic rickets maps to a 200-300kb region in Xp22.1-Xp22.2 and is located on a single YAC containing a putative vitamin D response element (VDRE). Hum Genet. 97:1996;345-352.
43. Rowe P.S., Ong A.C., Cockerill F.J., Goulding J.N., Hewison M. Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia. Bone. 18:1996;159-169.
44. Rowe P.S., Oudet C.L., Francis F., et al. Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet. 6:1997;539-549.
45. Ruchon A.F., Marcinkiewicz M., Siegfried G., et al. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem. 46:1998;459-468.
46. Scriver C.R., MacDonald W., Reade T., Glorieux R.H., Nogrady B. Hypophosphatemic nonrachitic bone disease an entity distinct from X-linked hypophosphatemia in the renal defect, bone involvement, and inheritance . Am J Med Gen. 1:1977;101-117.
47. Scriver C.R., Reade T.M., DeLuca H.F., Hamstra A.J. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med. 299:1978;976-979.
48. Strom T.M., Francis F., Lorenz B., et al. Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet. 6:1997;165-171.
49. Tenenhouse H.S., Beck L. Renal Na(+)-phosphate cotransporter gene expression in X-linked Hyp and Gy mice. Kid Int. 49:1996;1027-1032.
50. Tenenhouse, H. S. and Econs, M. J. Mendelian hypophosphatemias. In: The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill. In press.
51. Tenenhouse H.S., Klugerman A.H., Neal J.L. Effect of phosphonoformic acid, dietary phosphate and the HYP mutation on kinetically distinct phosphate transport processes in mouse kidney. Biochim Biophys Acta. 984:1989;207-213.
52. Thakker R.V., Read A.P., Davies K.E., et al. Bridging markers defining the map position of X-linked hypophosphatemic rickets. J Med Genet. 24:1987;756-760.
53. Vautour, L., Loertscher, R., Blydt-Hansen, T., Goodyear, P., and Goltzman, D. Renal transplantation does not reverse the metabolic abnormalities associated with X-linked hypophosphatemic rickets. Bone 23(Suppl.):181(Abstr.); 1988.
54. Vera C., Cure J.K., Naso W.B., et al. Paraplegia due to ossification of ligamenta flava in X-linked hypophosphatemia. Spine. 22:1997;710-715.
55. Welches W.R., Brosnihan K.B., Ferrario C.M. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sciences. 52:1993;1461-1480.
56. White K.E., Speer M.C., Biber J., Murer H., Econs M.J. Refining the autosomal dominant hypophosphatemic rickets (ADHR) interval on chromosome 12p13 and localization of two candidate ADHR genes. Bone. 23:1998;5379. (abstract).
57. Whyte M.P., Schrank F.W., Armamento V.R. X-linked hypophosphatemia A search for gender, race, anticipation, or parent of origin effects on disease expression in children . J Clin Endocrinol Metab. 81:1996;4075-4080.
58. Winters R.W., Graham J.B., Williams T.F., McFalls V.W., Burnett C.H. A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. Medicine. 37:1958;97-142.
59. Xu D., Emoto N., Giaid A., et al. ECE-1 a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 . Cell Nucleic Acids Res. 15:1987;8125-8148.